{"schema_version":"1","generated_at":"2026-11-19T01:09:50.043Z","data_as_of":null,"url":"https://www.findmykol.com/kol/john-taylor","json_url":"https://www.findmykol.com/kol/john-taylor/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"john-taylor","name":"John Taylor","credential":"MD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Saints Medical Group","institution_url":"https://www.findmykol.com/institution/saints-medical-group","city":"Oklahoma City","state":"OK","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1376589069"},"summary":"John Taylor is an Oncology physician affiliated with Saints Medical Group. ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":1,"shown":3,"withheld":2,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04608045","title":"Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"CicloMed LLC","source_url":"https://clinicaltrials.gov/study/NCT04608045","trial_url":"https://www.findmykol.com/trial/NCT04608045"},{"nct":"NCT04525131","title":"Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"CicloMed LLC","source_url":"https://clinicaltrials.gov/study/NCT04525131","trial_url":"https://www.findmykol.com/trial/NCT04525131"},{"nct":"NCT04046094","title":"Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients","phase":"PHASE1/PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"University of Kansas Medical Center","source_url":"https://clinicaltrials.gov/study/NCT04046094","trial_url":"https://www.findmykol.com/trial/NCT04046094"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":8,"shown":3,"withheld":5,"rows":[{"payer":"BIOPROTECT MEDICAL, INC.","program_year":2025,"amount_usd":70.88,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1376589069"},{"payer":"BIOPROTECT MEDICAL, INC.","program_year":2024,"amount_usd":122.63,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1376589069"},{"payer":"Sumitomo Pharma America, Inc.","program_year":2024,"amount_usd":23.93,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1376589069"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1376589069","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Genitourinary & hormones","share_pct":52.1,"classes_total":1,"classes":[{"class":"alpha-Adrenergic Blocker","setting":"prescribed","share_pct":52.1,"drugs":[{"name":"Tamsulosin Hcl","share_pct":100}],"max_beneficiaries":56}]},{"area":"Sensory organs","share_pct":16.7,"classes_total":2,"classes":[{"class":"Fluoroquinolone Antibacterial","setting":"prescribed","share_pct":12.2,"drugs":[{"name":"Ciprofloxacin Hcl","share_pct":100}],"max_beneficiaries":34},{"class":"Corticosteroid","setting":"prescribed","share_pct":4.5,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":15.6,"classes_total":2,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":11.5,"drugs":[{"name":"Oxycodone-Acetaminophen","share_pct":100}],"max_beneficiaries":null},{"class":"N-methyl-D-aspartate Receptor Antagonist","setting":"prescribed","share_pct":4.2,"drugs":[{"name":"Memantine Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"contact":{"address_1":"2525 NW EXPRESSWAY","address_2":"SUITE 404","city":"Oklahoma City","state":"OK","zip":"731127230","phone":"405-607-4520","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1376589069","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":5}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2012-05-15","collected_at":"2026-11-06T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}